Biotechnology
Molecular de-extinction opens possibilities for new antibiotics
Molecular de-extinction revives genes and proteins from ancient sources, and it may hold the key to new antibiotics that fight drug-resistant pathogens.
Bio
Angela Zhou is an Information Scientist at CAS. She earned her Ph.D. in Molecular Pharmacology and toxicology from University of Southern California. She was further trained as a cell biologist at Johns Hopkins School of Medicine and worked in the area of cancer biology at Harvard Medical School. She was a faculty member at Missouri State University and Denison University prior to joining CAS.
Emerging Science
The future of lipid-based drug delivery
Watch the recording of our webinar where experts from CAS, AstraZeneca, and The Ohio State University explored the current landscape and future directions of lipid-based drug delivery.
Emerging Science
Friend, not foe: Harnessing the gut microbiome for health benefits
The gut microbiome is a complex ecosystem of trillions of bacteria that live in our digestive tracts with health benefits like immunity, improved mental health, and therapeutic options.
Drug Discovery
ACE2: Targeting a potentially important receptor in disease pathogenesis
The ACE2 protein is the critical target for COVID-19 and other viral infections, and this knowledge has led to new therapeutics.
Emerging Science
Are psychedelics next to treat depression and PTSD?
Recent clinical trials show that psychedelics, when properly controlled, could be used to treat PTSD and other mental health disorders. Learn more.